News

News Center Maine, Feb. 3, 2022: Winter is a time when the risk of getting Lyme disease and other tick-borne infections is at its lowest. However, despite a drop in activity, deer ticks rarely die off even in harsh conditions because they can survive under snow cover. But if... Read More »

By Leslie Tate, Tulane University Even after antibiotic treatment, some Lyme disease patients suffer from an array of symptoms including neurological issues that greatly diminish their quality of life. Brain scans of these patients show persistent neuroinflammation, but the cause... Read More »

From “Frontiers in Public Health,” January 21, 2022 By Dr. Sam T. Donta We know the cause of Lyme disease. We know that the bacteria can be found in the initial rash, and occasionally in the blood in the subsequent 2–3 months, but after then, its subsequent location... Read More »

Officials report an “unusually high” infection rate of deer tick virus (DTV) detected in a Pennsylvania park. Out of 25 ticks recently collected from Lawrence Township Recreational Park in Clearfield County, 23 carried the dangerous virus. That’s a 92% infection rate. The... Read More »

By Virginia Commonwealth University (VCU) One of VCU’s most successful and revenue-generating inventors is on track to develop a vaccine against Lyme disease in humans as well as a new diagnostic test. The human vaccine work builds on a USDA-approved Lyme disease vaccine... Read More »

By Suhtling Wong-Vienneau, University of Central Florida Mollie Jewett, associate professor and head of the Immunity and Pathogenesis Division at the College of Medicine and Brian Kim an assistant professor in the College of Engineering and Computer Science, will split a $325,000... Read More »

Multiple sclerosis (MS), a progressive disease that affects 2.8 million people worldwide and for which there is no definitive cure, is likely caused by infection with the Epstein-Barr virus (EBV), according to a study led by Harvard T.H. Chan School of Public Health researchers.... Read More »

Discoveries by Japanese scientists may lead to the development of a safe and effective nasal spray to prevent dementia. Using mouse models, researchers from Osaka City University have found that nasal administration of two drugs—rifampicin and resveratrol—can improve cognitive... Read More »

Bonnie Crater, of the Center for Lyme Action, has sent out the following alert to Lyme advocates: We need your help. Please take a few minutes to ask your U.S. Representative to co-sponsor HR 5585, the ARPA-H Act. Here’s why it’s important. ARPA-H (Advanced Research... Read More »